Flunixin Meglumine Powder
Flunixin Meglumine is an FDA-approved preparation containing Flunixin Meglumine, for veterinary use. Available by prescription.
Powder medications are meant to be mixed into food or treats, not given on their own (since most pets won’t lick up plain powder). The key is to mix it into something tasty so your pet eats the entire dose.
How to Give It:
- Measure the dose using the included scoop or follow the instructions. If you’re unsure how much to give, ask your vet or pharmacist.
- Mix it with a small amount of soft food or treat—like wet food, baby food (meat flavor), peanut butter (xylitol-free), yogurt, or cheese. Use just enough to hide the powder so your pet finishes it all in one go.
- Stir it well to blend the powder in evenly. Add a splash of water if needed to make it smoother.
- Offer it when your pet is a little hungry, and watch to make sure they eat the whole thing.
- If your pet refuses, try something else they love next time. For cats, you can also try smearing the paste on their paw to lick off (only if safe and comfortable).
- For large animals, mix the powder into a small portion of feed with water or molasses, then follow with the rest of their food once they’ve eaten the medicated part.
- Store the powder in a cool, dry place with the lid closed tightly.
Never give powder straight into your pet’s mouth—it can be dangerous if inhaled.
Veterinarians most commonly consider flunixin meglumine when a patient is presented with musculoskeletal disorders or visceral pain, particularly in the context of equine colic. It is frequently a point of discussion for the management of inflammatory conditions associated with endotoxemia and respiratory disease in livestock. By modulating the biochemical mediators of inflammation, your veterinarian can manage the physiological environment during acute physical stress or recovery from injury.
At a pharmacological level, flunixin meglumine acts as a non-selective inhibitor of the cyclooxygenase (COX) enzyme. This enzyme is responsible for the conversion of arachidonic acid into prostaglandins, which are key lipid compounds that mediate the perception of discomfort, the development of localized swelling and the regulation of body temperature within the hypothalamus. Flunixin is characterized by its significant potency, often studied for its ability to provide clinical support at relatively low concentrations. Your veterinarian will determine the appropriate administration route and duration based on the patient's species, weight and the specific nature of the inflammatory or pain management requirements.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects of flunixin meglumine include gastrointestinal changes such as decreased appetite, loose stools or localized irritation of the digestive lining. Because this medication can influence renal blood flow and the protective mucosal barrier of the stomach, your veterinarian will monitor for signs of gastric ulcers or changes in kidney function, especially in dehydrated or senior patients. In horses, localized tissue reactions have been observed following certain injection routes, so your veterinarian will provide specific guidance on administration techniques. If you observe significant behavioral shifts, dark or tarry stools or signs of abdominal discomfort, contact your veterinarian promptly.This medication is typically used with extra caution or avoided in patients with known kidney or liver impairment, pre-existing gastrointestinal ulcers or known hypersensitivity to NSAIDs. It is also carefully evaluated in pregnant or lactating animals, as salicylates and related compounds can influence physiological signals associated with gestation. Before starting a protocol involving flunixin meglumine, ensure your veterinarian has a complete history of all other supplements and prescriptions your animal is receiving, as concurrent use with other NSAIDs or corticosteroids is generally avoided. Your veterinarian is the right person to assess your animal's individual health profile and determine the appropriate monitoring necessary during administration.
Yes. Flunixin meglumine is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home or farm.
Yes. While flunixin meglumine is available in several commercial injectable and paste formats, Mixlab can compound this medication into specialized strengths or flavored oral dosage forms if your veterinarian determines a customized preparation better suits your animal's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians frequently consider flunixin meglumine in equine colic cases because of its efficacy in managing visceral discomfort and its role in addressing the inflammatory response associated with endotoxemia. It is often a primary component of the clinical management plan while the underlying cause of the colic is being addressed.
Owners should monitor for changes in appetite and manure consistency, as well as any signs of discomfort that might suggest gastric sensitivity. If the medication was administered via injection, you should also check the site for any unusual swelling or heat and report these findings to your veterinarian.
